XML 88 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Payment Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangements [Abstract]  
Schedule of Number and Weighted-Average Exercise Prices of Other Equity Instruments The first cycle commenced in 2021, with delivery of the respective shares in 2024. The maximum number of shares assigned to this cycle of the plan was 19,425,499 and the outstanding shares at December 31, 2022 was 18,544,534, with the following breakdown:
First cycleNo. of shares assignedOutstanding shares at 12/31/2022Unit fair value (euros)
TSR Objective9,712,750 9,272,267 2.64 
FCF Objective7,770,200 7,417,814 3.15 
CO2 E.N. Objective1,942,550 1,854,453 3.15 
The second cycle commenced in 2022, with delivery of the respective shares in 2025. The maximum number of shares assigned to this cycle of the plan was 15,069,650 and the outstanding shares at December 31, 2022 was 14,969,799, with the following breakdown:
Second cycleNo. of shares assignedOutstanding shares at 12/31/2022Unit fair value (euros)
TSR Objective7,534,825 7,484,899 2.43 
FCF Objective6,027,860 5,987,920 2.95 
CO2 E.N. Objective1,506,965 1,496,980 2.95 
The first cycle commenced in 2021, with delivery of the respective shares in 2024. The maximum number of shares assigned to this cycle of the plan was 1,751,500 and the outstanding shares at December 31, 2022 was 1,659,500, with the following breakdown:
First cycleNo. of shares assignedOutstanding shares at 12/31/2022Unit fair value (euros)
TSR Objective875,750 829,750 2.64 
FCF Objective700,600 663,800 3.15 
CO2 E.N. Objective175,150 165,950 3.15 
The second cycle commenced in 2022, with delivery of the respective shares in 2025. The maximum number of shares assigned to this cycle of the plan was 1,646,500 and the outstanding shares at December 31, 2022 was 1,611,000, with the following breakdown:
Second cycleNo. of shares assignedOutstanding shares at 12/31/2022Unit fair value (euros)
TSR Objective823,250 805,500 2.43 
FCF Objective658,600 644,400 2.95 
CO2 E.N. Objective164,650 161,100 2.95